Key Takeaways
ICD-10 Code G10 is the sole billable ICD-10-CM diagnosis code for confirmed Huntington’s disease, with no subcodes or child codes.
G10 falls under block G10-G14 (Systemic atrophies primarily affecting the central nervous system) within chapter G00-G99 (Diseases of the nervous system).
G10 should only be assigned for confirmed HD diagnoses; presymptomatic gene-positive individuals require different coding consideration.
Pabau’s claims management software and structured patient records support accurate G10 documentation and clean claim submission.
ICD-10 Code G10: Definition and classification
ICD-10 Code G10 is the single billable ICD-10-CM diagnosis code for Huntington’s disease. It covers all confirmed presentations of the condition, regardless of clinical stage or symptom profile. This guide covers the classification hierarchy, synonyms, related codes, documentation requirements, and common coding pitfalls for accurate diagnosis reporting in 2026. For psychiatry EMR software users managing complex neurological and neuropsychiatric patients, understanding the nuances of G10 is foundational to clean claim submission.
Code classification hierarchy
G10 sits within a clearly defined hierarchical structure in CMS ICD-10-CM:
- Chapter: G00-G99 – Diseases of the nervous system
- Block: G10-G14 – Systemic atrophies primarily affecting the central nervous system
- Code: G10 – Huntington’s disease
G10 is a terminal code with no further subcodes. There is no G10.0, G10.1, or equivalent specificity option available in ICD-10-CM. The code covers all confirmed clinical presentations of HD, including the classical chorea-dominant form and less common variants.
Billable status
G10 is a billable, specific diagnosis code. It is valid for submission on Medicare, Medicaid, and commercial insurance claims for fiscal year 2026. No additional specificity is required beyond this single code to meet the minimum coding standard for a confirmed HD diagnosis.
ICD-10 Code G10: Clinical description and synonyms
Huntington’s disease is an autosomal dominant hereditary neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the huntingtin gene (HTT) on chromosome 4. Progressive degeneration of the basal ganglia drives the characteristic triad of motor dysfunction, cognitive decline, and neuropsychiatric manifestations.
For the purposes of patient care management and documentation, the three core domains are worth flagging in the clinical record even when only G10 is assigned:
- Motor: Chorea (involuntary, irregular, rapid movements), bradykinesia, dystonia, oculomotor abnormalities, and dysarthria
- Cognitive: Executive dysfunction, visuospatial impairment, and dementia in later stages
- Neuropsychiatric: Depression, anxiety, irritability, apathy, obsessive-compulsive behaviors, and psychosis
The WHO ICD-10 browser lists Huntington’s disease under “degenerative diseases of the basal ganglia,” reflecting the anatomical basis of the movement disorder. The ICD-10-CM tabular list includes the following official synonyms under G10:
- Akinetic-rigid form of Huntington’s disease
- Altered behavior in Huntington’s disease
- Westphal variant of Huntington’s disease
- Huntington’s chorea
These synonyms are not separate codes. All are captured under the single G10 designation, regardless of which variant or manifestation is documented.
ICD-9-CM crosswalk
For practices transitioning legacy data or reviewing historical claims, the ICD-9-CM equivalent of G10 was code 333.4 (Huntington’s chorea). This was a direct crosswalk conversion when ICD-10-CM was mandated for U.S. healthcare claims under HIPAA on October 1, 2015.
Pro Tip
When auditing pre-2015 claims or reconciling legacy patient records, map ICD-9 code 333.4 to G10. The crosswalk is one-to-one, so no additional specificity mapping is required. Flag any records still carrying 333.4 in an active billing system for immediate correction.
ICD-10 Code G10 documentation requirements
Accurate G10 assignment hinges on confirmed diagnosis documentation. Unlike many ICD-10-CM codes where “probable” or “suspected” language may be acceptable depending on the clinical context, Huntington’s disease coding requires documented confirmation before G10 is assigned. The ICD-10-CM Official Guidelines for Coding and Reporting specify that confirmed diagnoses, not symptoms alone, drive code selection for definitive neurological conditions.
Using digital intake forms and structured clinical templates ensures the right documentation fields are captured at the point of care, reducing the risk of submitting G10 on an incomplete or ambiguous clinical record.

What constitutes a confirmed HD diagnosis?
Confirmation typically requires genetic testing demonstrating a pathogenic CAG repeat expansion (36 or more repeats, with 36-39 representing reduced-penetrance alleles and 40 or more representing full penetrance) in the HTT gene, combined with a clinical presentation consistent with HD. Document both in the medical record before assigning G10. A positive genetic test result in an asymptomatic individual does not automatically support G10 assignment; the patient must have clinical manifestations of HD.
- Required in clinical record: CAG repeat expansion result (with repeat count) from a validated genetic laboratory
- Required in clinical record: Neurological examination findings consistent with HD (chorea, cognitive changes, or neuropsychiatric features)
- Required in clinical record: Clinician statement confirming Huntington’s disease diagnosis
- Avoid: Assigning G10 solely on family history or genetic risk without confirmed clinical presentation
Structured patient records that include dedicated fields for genetic test results and movement disorder examinations reduce documentation gaps that trigger claim reviews. The private practice time-saving features in modern EHR platforms make this structured capture practical even in high-volume neurology settings.

Presymptomatic gene-positive individuals
A gene-positive but clinically asymptomatic individual should not receive a G10 code. These patients carry the mutation and will likely develop HD, but they do not yet have the condition. Coding options for presymptomatic individuals include Z15.89 (Genetic susceptibility to other disease) or Z82.0 (Family history of epilepsy and other diseases of the nervous system), depending on the clinical context and payer requirements. Always verify with the relevant payer before assigning a code for presymptomatic carrier status.
Simplify neurological documentation with Pabau
Pabau helps neurology and movement disorder practices capture structured clinical data, manage genetic test documentation, and submit clean claims for complex diagnoses like G10. See how it works.
Related and associated ICD-10 codes for Huntington’s disease
HD is a multisystem condition. Coders and clinicians managing HD patients frequently encounter situations where additional codes are needed to fully capture the patient’s clinical picture. The following codes are commonly used alongside G10.
Cognitive and neuropsychiatric codes
When cognitive impairment or specific neuropsychiatric manifestations are documented and managed as distinct clinical problems, they may warrant additional coding. The CDC/NCHS ICD-10-CM web tool confirms the following as commonly associated codes:
Coding these as additional codes alongside G10 is appropriate when each condition is separately evaluated, documented, and managed during the encounter. Do not assign them simply because they are common HD features; each requires explicit documentation as a current clinical problem.
Differential and related neurological codes
Several neurological conditions share phenotypic overlap with HD and frequently appear in the differential diagnosis or in the same patient record. Understanding the distinctions supports more accurate neurological disorder ICD-10 codes selection:
- G11 (Hereditary ataxia): Distinguished from HD by the ataxia-dominant phenotype and different genetic basis; spinocerebellar ataxias are the main differential
- G20 (Parkinson’s disease): The akinetic-rigid variant of HD (Westphal variant) can resemble Parkinson’s disease clinically; genetic confirmation distinguishes them
- G30 (Alzheimer’s disease): Late-stage HD dementia may superficially resemble Alzheimer’s; G10 is correct when HD etiology is confirmed
- G31.09 (Other frontotemporal neurocognitive disorder): Frontotemporal features in HD are increasingly recognized; assign G10 as the principal code with additional cognitive codes as appropriate
For complex neuropsychiatric presentations involving anxiety disorder ICD-10 coding alongside a confirmed neurodegenerative diagnosis, document each condition separately and assign codes in order of clinical priority for the encounter. Similarly, when managing patients with comorbid neurodevelopmental condition ICD-10 coding concerns, each condition should be independently substantiated in the record.
Pro Tip
When G10 is the principal diagnosis for an encounter, sequence it first. Additional codes for dementia (F02.80 or F02.81), mild cognitive impairment (F06.70 or F06.71), or neuropsychiatric manifestations follow G10 in order of clinical significance. Never sequence a manifestation code before the underlying disease code unless payer-specific guidelines require otherwise.
Coding best practices for ICD-10 Code G10
Clean claims for G10 require more than correct code selection. The following workflow practices reduce denial rates and audit exposure for neurology and movement disorder practices.
Common coding errors to avoid
The most frequent G10 coding errors fall into four categories:
- Assigning G10 for gene-positive but asymptomatic patients. Confirmed genetic carrier status without clinical manifestations does not support G10. Use Z15.89 instead.
- Failing to add dementia codes when HD-related cognitive decline is separately managed. G10 alone does not capture dementia; if F02.80 or F02.81 are clinically warranted, include them as additional codes.
- Using G10 for suspected or probable HD. ICD-10-CM guidelines for nervous system diseases require confirmed diagnosis. “Suspected Huntington’s” should be coded using the presenting symptom (e.g., R25.1 for tremor, R25.2 for cramps and spasms) until confirmation is established.
- Applying G10 without linking to relevant CPT procedure codes. G10 as a standalone diagnosis code without appropriate evaluation and management CPT codes may trigger medical necessity questions. Ensure the procedure-to-diagnosis link is documented clearly.
Multidisciplinary team documentation
HD care typically involves neurologists, psychiatrists, speech therapists, physical therapists, and genetic counselors. Each clinician’s documentation contributes to the overall clinical picture, but only the treating physician or clinician of record should assign the primary diagnosis code for billing purposes. Coordination notes from allied health team members support the complexity level for evaluation and management coding but do not independently justify G10.
Robust EHR integration for documentation across the multidisciplinary team reduces fragmentation in the clinical record and ensures that all contributors to the HD diagnosis are captured in a single longitudinal record. This matters for both coding accuracy and continuity of care.
Using coding tools effectively
The AAPC Codify ICD-10-CM lookup and the ICD List tool both provide free access to G10 code details, synonyms, and cross-references. For practices building internal coding reference materials, these resources confirm that G10 has no excludes notes and no mandatory additional code requirements, making it one of the cleaner codes to manage in the neurological disease category.
Integrated claims management software that flags incomplete diagnosis documentation before claim submission catches G10-related errors at the point of coding rather than at the payer level. This reduces rework and accelerates reimbursement cycles for neurology practices managing complex, long-term HD cases.

Conclusion
ICD-10 Code G10 is straightforward in structure but demands precision in application. Confirmed diagnosis, accurate sequencing, and appropriate additional codes for dementia and neuropsychiatric manifestations are where most practices either get it right or create unnecessary billing friction.
Pabau’s structured patient records and integrated claims management tools help neurology and movement disorder practices build the documentation foundation that G10 requires, from genetic test result capture through to clean claim submission. To see how Pabau supports complex neurological diagnosis workflows, book a demo.
Continue your research
Need a structured approach to neurological patient records? Client records in Pabau provides a structured framework for capturing genetic test results, examination findings, and longitudinal clinical notes for HD patients.
Looking for guidance on psychiatric and neuropsychiatric coding? Psychiatry EMR software covers how practice management tools support complex neuropsychiatric workflows.
Want to reduce claim denials across your neurology practice? Claims management software walks through how integrated billing tools catch diagnosis-to-procedure mismatches before submission.
Frequently Asked Questions
ICD-10 Code G10 is the single billable ICD-10-CM diagnosis code for Huntington’s disease, a hereditary neurodegenerative disorder caused by a CAG repeat expansion in the huntingtin gene. It is classified under block G10-G14 (Systemic atrophies primarily affecting the central nervous system) within chapter G00-G99 (Diseases of the nervous system) and is valid for fiscal year 2026 claims.
Yes, G10 is a fully billable and specific ICD-10-CM diagnosis code with no subcodes or child codes. It can be submitted directly on Medicare, Medicaid, and commercial insurance claims without requiring additional specificity.
The ICD-9-CM equivalent was code 333.4 (Huntington’s chorea). The crosswalk is one-to-one and was established when ICD-10-CM became mandatory for U.S. claims on October 1, 2015.
No. G10 requires a confirmed clinical diagnosis of Huntington’s disease. A gene-positive but asymptomatic individual should be coded using Z15.89 (Genetic susceptibility to other disease) rather than G10, as there are no clinical manifestations to support the diagnosis code at that stage.
When HD-related dementia is documented, F02.80 (without behavioral disturbance) or F02.81 (with behavioral disturbance) may be assigned as additional codes. F06.70 or F06.71 is appropriate for documented mild neurocognitive disorder (without or with behavioral disturbance, respectively; F06.7 itself is a non-billable parent code). Each additional code requires explicit documentation as a separately managed clinical problem during the encounter.
Accurate G10 documentation requires a confirmed clinician statement of Huntington’s disease diagnosis, genetic test results showing a pathogenic CAG repeat expansion (36 or more repeats, with 36-39 reduced penetrance and 40 or more full penetrance), and examination findings consistent with HD. Symptom-only documentation without genetic confirmation should use symptom codes until diagnosis is established.